HLA-C and breast carcinoma: Breast cancer cells are thought to be continuously monitored by host resistance mechanisms (immunosurveillance [27]), as evidenced by linkage of MHC expression (Class I) with breast cancer growth [28]–[30], as well as analysis of the role of other immune parameters on disease incidence/progression [31]–[34].